This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Nocturia
and you are
over 65
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The main purpose of the study is to evaluate the way VA106483 enters and leaves the blood and tissues over time and how the drug acts on and in the body at various dose levels compared to placebo in the same volunteer.

Provided treatments

  • Drug: VA106483
  • Drug: Placebo
Tris trial is registered with FDA with number: NCT00922740. The sponsor of the trial is Vantia Ltd and it is looking for 10 volunteers for the current phase.
Official trial title:
An Open Label, Escalation Study to Assess Intra-Subject Dose Response to VA106483 in Elderly Male Subjects